Billionaire Profile
Martine Rothblatt
Global Rank
#2379

Image: -20140912-Martine-Rothblatt-5773.jpg: Owner and Copyright holder is Andre Chung derivative work: Bit7ocker | CC BY-SA 4.0 | via Wikimedia Commons

Martine Rothblatt

CEO, Pharmaceuticals
UNITED STATES
Real-Time Net Worth
$1.626B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
-0.9% (24h)
Age
71
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
UNITED STATES

Biography

Martine Rothblatt (born 1954) is an American lawyer, author, and entrepreneur with a net worth estimated at $380 million to $1 billion as of 2024. Her wealth stems from her pioneering work in the pharmaceutical industry, particularly through her company United Therapeutics. Rothblatt's career began in satellite communications law, later evolving to include life sciences. A pivotal moment came when her daughter was diagnosed with pulmonary arterial hypertension. Driven by this, Rothblatt founded United Therapeutics in 1996, developing life-saving treatments. She is known for her innovative approach, including research in xenotransplantation and electric aviation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Martine Rothblatt was born in Chicago, Illinois, in 1954. Rothblatt's early life included a passion for music and a fascination with satellite technology. This early interest was sparked by a tour of a satellite facility in the Seychelles. Rothblatt graduated from UCLA with a combined law and MBA degree in 1981.

Rise to Success

After graduating, Rothblatt worked in telecommunications law, representing the television industry before the Federal Communications Commission. She co-founded Sirius Satellite Radio in 1990, leading its 1993 IPO, and later founded United Therapeutics in 1996 after her daughter was diagnosed with pulmonary arterial hypertension.

Key Business Strategies

Rothblatt's strategy involves a combination of innovation and dedication. United Therapeutics has been at the forefront of developing treatments for pulmonary hypertension, and recently has been pushing its subsidiary Revivicor into xenotransplantation, specifically manufacturing pig organs to transplant into humans with end-stage renal and cardiac diseases.

Philanthropy

Martine Rothblatt is known for her philanthropy, particularly through her commitment to research and development in the areas of cryogenics, biotechnology, and cyber consciousness. She launched the Terasem Movement in 2004, a transhumanist school of thought focused on promoting joy, diversity, and the prospect of technological immortality.

Career Milestones

1981

Graduated from UCLA

Obtained J.D. and M.B.A. degrees from the University of California, Los Angeles.

1990

Co-founded Sirius Satellite Radio

Co-founded Sirius Satellite Radio, the first non-geostationary satellite-to-car broadcasting system.

1996

Founded United Therapeutics

Founded United Therapeutics to develop treatments for pulmonary arterial hypertension.

2018

Top Earning CEO

Was the top-earning CEO in the biopharmaceutical industry.

2024

Billionaire

Forbes estimates Rothblatt's net worth has hit the $1 billion mark.

Philanthropy & Social Impact

Medical Research

PPH Cure Foundation

Unknown

Founded to support research and find a cure for pulmonary hypertension.

Transhumanism

Terasem Movement Foundation

Unknown

Promotes technological immortality and transhumanist ideals.

Business Philosophy & Leadership

Notable Quotes

""I'm a person who likes to hear why something can't be done and I'll whittle down every one of the can'ts one at a time.""

Leadership Principles

Innovation

Embracing new ideas and technologies to improve human health and well-being.

Perseverance

Overcoming obstacles and challenges to achieve goals.

Advocacy

Speaking out for transgender rights and promoting acceptance.